Patient engagement in type 2 diabetes mellitus research: what patients want

被引:10
|
作者
Simacek, Kristina F. [1 ]
Nelson, Tanya [2 ]
Miller-Baldi, Mignon [3 ]
Bolge, Susan C. [2 ]
机构
[1] PatientsLikeMe, 160 2nd St, Cambridge, MA 02142 USA
[2] Janssen Sci Affairs LLC, Raritan, NJ USA
[3] Janssen Med Informat Ctr, Titusville, NJ USA
来源
关键词
qualitative research; patient engagement; patient involvement; research priorities; diabetes mellitus; social networking; social media; RESEARCH PRIORITIES; OUTCOMES RESEARCH; POWERED RESEARCH; RESEARCH AGENDA; FOCUS GROUP; HEALTH; PERSPECTIVES; COMMUNITY; PEOPLE; CANCER;
D O I
10.2147/PPA.S159707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: As patients are the ultimate stakeholder in their health, their perspectives should be included along with researchers, providers, and fenders of research design, execution, and interpretation. Despite the high prevalence of type 2 diabetes mellitus (T2DM), patients are rarely directly included in these decisions. Purpose: We sought to determine areas of research most important to patients with T2DM, identify ways through which patients with T2DM want to engage in research, and evaluate online patient research networks as a source for obtaining patient perspectives on research engagement. Patients and methods: This study used an online patient community forum (PatientsLikeMe) to host two asynchronous moderated discussions, each with three to four prompted discussion posts. A qualitative summary of themes was derived from the posts. Results: Eighty-eight participants with T2DM took part. Participants were mostly white (86%), averaged 58.6 years of age, half were female (50%), and over half (62%) resided in the US. Research priorities included managing T2DM with comorbidities, controlling blood sugar levels, finding a cure, and understanding causes of T2DM. Participants wanted to see direct applications of research to their lives. Clinical research was perceived to have overly restrictive eligibility criteria and to measure outcome sets that do not adequately address patient health concerns. Participants indicated broad interest in partnering in research and a willingness to apply their skills and educational background to specific stages in the research process. Conclusion: Patients with T2DM would like researchers to address outcomes that have meaning in patients' daily lives. Initiatives to involve patients in research should leverage and enable patients to contribute as participants, advisors, or co-investigators, going beyond research topic prioritization to full participation throughout the research process based on their abilities and interest. This study provides support for the use of online patient research network discussions to generate rich qualitative data to engage patients in research.
引用
收藏
页码:595 / 606
页数:12
相关论文
共 50 条
  • [21] What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives
    Alfieri, Carlo Maria
    Molinari, Paolo
    Cinque, Felice
    Vettoretti, Simone
    Cespiati, Annalisa
    Bignamini, Daniela
    Nardelli, Luca
    Fracanzani, Anna Ludovica
    Castellano, Giuseppe
    Lombardi, Rosa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [22] Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study
    Tan, A. M.
    Muthusamy, L.
    Ng, C. C.
    Phoon, K. Y.
    Ow, J. H.
    Tan, N. C.
    SINGAPORE MEDICAL JOURNAL, 2011, 52 (11) : 801 - 809
  • [23] Hypoglycemia in patients with type 2 diabetes mellitus
    Miller, CD
    Phillips, LS
    Ziemer, DC
    Gallina, DL
    Cook, CB
    El-Kebbi, IM
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1653 - 1659
  • [24] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [25] BMD IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Sensoy, Nazli
    Karademir, Nur
    Demirdal, Umit
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S372 - S372
  • [26] Monotherapy in Patients with Type 2 Diabetes Mellitus
    Rhee, Sang Youl
    Kim, Hyun Jin
    Ko, Seung-Hyun
    Hur, Kyu-Yeon
    Kim, Nan-Hee
    Moon, Min Kyong
    Park, Seok-O
    Lee, Byung-Wan
    Choi, Kyung Mook
    Kim, Jin Hwa
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 349 - 356
  • [27] Monotherapy in patients with type 2 diabetes mellitus
    Rhee, Sang Youl
    Kim, Hyun Jin
    Ko, Seung-Hyun
    Hur, Kyu Yeon
    Kim, Nan-Hee
    Moon, Min Kyong
    Park, Seok-O
    Lee, Byung-Wan
    Choi, Kyung Mook
    Kim, Jin Hwa
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (06): : 959 - 966
  • [28] Nephropathy in patients with type 2 diabetes mellitus
    Ritz, E
    Orth, SR
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15): : 1127 - 1133
  • [29] Anemia in Patients with Type 2 Diabetes Mellitus
    Barbieri, Jessica
    Fontela, Paula Caitano
    Winkelmann, Eliane Roseli
    Prestes Zimmermann, Carine Eloise
    Sandri, Yana Picinin
    Viera Mallet, Emanelle Kerber
    Frizzo, Matias Nunes
    ANEMIA, 2015, 2015
  • [30] Osteoporosis in patients with type 2 diabetes mellitus
    Jawad, Ali S.
    SAUDI MEDICAL JOURNAL, 2023, 44 (12) : 1221 - 1221